Goldschmidt H - Search Results

1

The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.

Weinhold N, Johnson DC, Chubb D, Chen B, Försti A, Hosking FJ, Broderick P, Ma YP, Dobbins SE, Hose D, Walker BA, Davies FE, Kaiser MF, Li NL, Gregory WA, Jackson GH, Witzens-Harig M, Neben K, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Ross FM, Jauch A, Goldschmidt H, Houlston RS, Morgan GJ, Hemminki K. Weinhold N, et al. Among authors: goldschmidt h. Nat Genet. 2013 May;45(5):522-525. doi: 10.1038/ng.2583. Epub 2013 Mar 17. Nat Genet. 2013. PMID: 23502783 Free PMC article.

2

Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.

Neben K, Mytilineos J, Moehler TM, Preiss A, Kraemer A, Ho AD, Opelz G, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Blood. 2002 Sep 15;100(6):2263-5. Blood. 2002. PMID: 12200397 Free article. Clinical Trial.

3

Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.

Neben K, Moehler T, Benner A, Kraemer A, Egerer G, Ho AD, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Clin Cancer Res. 2002 Nov;8(11):3377-82. Clin Cancer Res. 2002. PMID: 12429624 Clinical Trial.

4

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.

Witzens M, Moehler T, Neben K, Fruehauf S, Hartschuh W, Ho AD, Goldschmidt H. Witzens M, et al. Among authors: goldschmidt h. Ann Hematol. 2004 Jul;83(7):467-70. doi: 10.1007/s00277-003-0804-0. Epub 2003 Nov 19. Ann Hematol. 2004. PMID: 14625789

5

Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.

Cremer FW, Bila J, Buck I, Kartal M, Hose D, Ittrich C, Benner A, Raab MS, Theil AC, Moos M, Goldschmidt H, Bartram CR, Jauch A. Cremer FW, et al. Among authors: goldschmidt h. Genes Chromosomes Cancer. 2005 Oct;44(2):194-203. doi: 10.1002/gcc.20231. Genes Chromosomes Cancer. 2005. PMID: 16001433

6

High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.

Cremer FW, Kartal M, Hose D, Bila J, Buck I, Bellos F, Raab MS, Brough M, Moebus A, Hager HD, Goldschmidt H, Moos M, Bartram CR, Jauch A. Cremer FW, et al. Among authors: goldschmidt h. Cancer Genet Cytogenet. 2005 Sep;161(2):116-24. doi: 10.1016/j.cancergencyto.2005.02.015. Cancer Genet Cytogenet. 2005. PMID: 16102581

7

Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.

Hundemer M, Schmidt S, Condomines M, Lupu A, Hose D, Moos M, Cremer F, Kleist C, Terness P, Belle S, Ho AD, Goldschmidt H, Klein B, Christensen O. Hundemer M, et al. Among authors: goldschmidt h. Exp Hematol. 2006 Apr;34(4):486-96. doi: 10.1016/j.exphem.2006.01.008. Exp Hematol. 2006. PMID: 16569595 Free PMC article.

8

Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A).

Li G, Hundemer M, Wolfrum S, Ho AD, Goldschmidt H, Witzens-Harig M. Li G, et al. Among authors: goldschmidt h. Ann Hematol. 2006 Sep;85(9):583-90. doi: 10.1007/s00277-006-0137-x. Epub 2006 May 23. Ann Hematol. 2006. PMID: 16718496

9

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.

Bochtler T, Hegenbart U, Cremer FW, Heiss C, Benner A, Hose D, Moos M, Bila J, Bartram CR, Ho AD, Goldschmidt H, Jauch A, Schonland SO. Bochtler T, et al. Among authors: goldschmidt h. Blood. 2008 May 1;111(9):4700-5. doi: 10.1182/blood-2007-11-122101. Epub 2008 Feb 27. Blood. 2008. PMID: 18305218 Free article.

10

Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma.

Hillengass J, Zechmann CM, Nadler A, Hose D, Cremer FW, Jauch A, Heiss C, Benner A, Ho AD, Bartram CR, Kauczor HU, Delorme S, Goldschmidt H, Moehler TM. Hillengass J, et al. Among authors: goldschmidt h. Int J Cancer. 2008 Jun 15;122(12):2871-5. doi: 10.1002/ijc.23455. Int J Cancer. 2008. PMID: 18351576 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

817 results

Search Page